(MTH) Meritage - Ratings and Ratios
Houses,Mortgages,Title,Insurance
MTH EPS (Earnings per Share)
MTH Revenue
Description: MTH Meritage
Meritage Homes Corporation is a leading homebuilder in the United States, operating through two segments: Homebuilding and Financial Services. The company designs and builds single-family attached and detached homes, primarily targeting entry-level and first-time move-up buyers across 11 states, including Arizona, California, and Texas.
The companys business model involves acquiring and developing land, constructing, marketing, and selling homes. Additionally, Meritage Homes provides a range of financial services, including title and escrow, mortgage, insurance, and closing/settlement services to its homebuyers, creating a comprehensive ecosystem for its customers.
From a performance perspective, key metrics to consider include the companys home closing prices, homebuilding margins, and sales per community. Meritage Homes ability to manage its land inventory, control costs, and execute its pricing strategy will be crucial in driving its profitability. With a market capitalization of over $5 billion, the companys scale and operational efficiency will be important factors in its ability to navigate the competitive homebuilding landscape.
In terms of valuation, Meritage Homes price-to-earnings ratio of 7.08 and forward P/E of 8.18 suggest a relatively attractive valuation compared to its peers. The companys return on equity (RoE) of 14.28% indicates a strong ability to generate profits from shareholder equity. Other key performance indicators (KPIs) to monitor include the companys debt-to-equity ratio, interest coverage, and return on assets (RoA).
MTH Stock Overview
| Market Cap in USD | 5,463m |
| Sub-Industry | Homebuilding |
| IPO / Inception | 1988-07-20 |
MTH Stock Ratings
| Growth Rating | 25.9% |
| Fundamental | 56.3% |
| Dividend Rating | 52.4% |
| Return 12m vs S&P 500 | -32.8% |
| Analyst Rating | 3.83 of 5 |
MTH Dividends
| Dividend Yield 12m | 2.66% |
| Yield on Cost 5y | 4.24% |
| Annual Growth 5y | 66.67% |
| Payout Consistency | 19.4% |
| Payout Ratio | 15.0% |
MTH Growth Ratios
| Growth Correlation 3m | 87.5% |
| Growth Correlation 12m | -66.5% |
| Growth Correlation 5y | 76.2% |
| CAGR 5y | 30.47% |
| CAGR/Max DD 3y | 0.75 |
| CAGR/Mean DD 3y | 3.53 |
| Sharpe Ratio 12m | -0.43 |
| Alpha | -36.54 |
| Beta | 0.980 |
| Volatility | 38.04% |
| Current Volume | 706.6k |
| Average Volume 20d | 853.7k |
| Stop Loss | 76.4 (-3%) |
| Signal | -1.09 |
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (805.4m TTM) > 0 and > 6% of Revenue (6% = 371.7m TTM) |
| FCFTA -0.03 (>2.0%) and ΔFCFTA -7.89pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 15.49% (prev 90.61%; Δ -75.13pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.03 (>3.0%) and CFO -220.4m <= Net Income 805.4m (YES >=105%, WARN >=100%) |
| Net Debt (871.1m) to EBITDA (1.02b) ratio: 0.85 <= 3.0 (WARN <= 3.5) |
| Current Ratio 4.96 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (71.7m) change vs 12m ago -2.39% (target <= -2.0% for YES) |
| Gross Margin 22.71% (prev 26.21%; Δ -3.50pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 84.39% (prev 93.32%; Δ -8.93pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 180.5 (EBITDA TTM 1.02b / Interest Expense TTM 5.54m) >= 6 (WARN >= 3) |
Altman Z'' 6.11
| (A) 0.12 = (Total Current Assets 1.20b - Total Current Liabilities 242.1m) / Total Assets 7.76b |
| (B) 0.67 = Retained Earnings (Balance) 5.21b / Total Assets 7.76b |
| (C) 0.14 = EBIT TTM 999.1m / Avg Total Assets 7.34b |
| (D) 2.09 = Book Value of Equity 5.21b / Total Liabilities 2.49b |
| Total Rating: 6.11 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 56.27
| 1. Piotroski 5.50pt = 0.50 |
| 2. FCF Yield -4.03% = -2.01 |
| 3. FCF Margin -4.14% = -1.55 |
| 4. Debt/Equity 0.35 = 2.44 |
| 5. Debt/Ebitda 1.78 = 0.42 |
| 6. ROIC - WACC 4.40% = 5.50 |
| 7. RoE 15.61% = 1.30 |
| 8. Rev. Trend -17.09% = -0.85 |
| 9. Rev. CAGR 0.70% = 0.09 |
| 10. EPS Trend -14.18% = -0.35 |
| 11. EPS CAGR 7.91% = 0.79 |
What is the price of MTH shares?
Over the past week, the price has changed by -4.08%, over one month by +2.32%, over three months by +22.00% and over the past year by -20.47%.
Is Meritage a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MTH is around 85.85 USD . This means that MTH is currently overvalued and has a potential downside of 8.96%.
Is MTH a buy, sell or hold?
- Strong Buy: 4
- Buy: 2
- Hold: 6
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the MTH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 86.1 | 9.3% |
| Analysts Target Price | 86.1 | 9.3% |
| ValueRay Target Price | 94.6 | 20.1% |
Last update: 2025-09-05 04:52
MTH Fundamental Data Overview
CCE Cash And Equivalents = 930.5m USD (last quarter)
P/E Trailing = 8.7548
P/E Forward = 8.8106
P/S = 0.8789
P/B = 1.0301
P/EG = 1.28
Beta = 1.292
Revenue TTM = 6.19b USD
EBIT TTM = 999.1m USD
EBITDA TTM = 1.02b USD
Long Term Debt = 1.83b USD (from longTermDebt, last quarter)
Short Term Debt = unknown (0.0)
Debt = 1.83b USD (Calculated: Short Term 0.0 + Long Term 1.83b)
Net Debt = 871.1m USD (from netDebt column, last quarter)
Enterprise Value = 6.36b USD (5.46b + Debt 1.83b - CCE 930.5m)
Interest Coverage Ratio = 180.5 (Ebit TTM 999.1m / Interest Expense TTM 5.54m)
FCF Yield = -4.03% (FCF TTM -256.2m / Enterprise Value 6.36b)
FCF Margin = -4.14% (FCF TTM -256.2m / Revenue TTM 6.19b)
Net Margin = 13.00% (Net Income TTM 805.4m / Revenue TTM 6.19b)
Gross Margin = 22.71% ((Revenue TTM 6.19b - Cost of Revenue TTM 4.79b) / Revenue TTM)
Tobins Q-Ratio = 1.22 (Enterprise Value 6.36b / Book Value Of Equity 5.21b)
Interest Expense / Debt = 0.05% (Interest Expense 842.0k / Debt 1.83b)
Taxrate = 21.61% (216.7m / 1.00b)
NOPAT = 783.3m (EBIT 999.1m * (1 - 21.61%))
Current Ratio = 4.96 (Total Current Assets 1.20b / Total Current Liabilities 242.1m)
Debt / Equity = 0.35 (Debt 1.83b / last Quarter total Stockholder Equity 5.27b)
Debt / EBITDA = 1.78 (Net Debt 871.1m / EBITDA 1.02b)
Debt / FCF = -7.13 (Debt 1.83b / FCF TTM -256.2m)
Total Stockholder Equity = 5.16b (last 4 quarters mean)
RoA = 10.38% (Net Income 805.4m, Total Assets 7.76b )
RoE = 15.61% (Net Income TTM 805.4m / Total Stockholder Equity 5.16b)
RoCE = 14.30% (Ebit 999.1m / (Equity 5.16b + L.T.Debt 1.83b))
RoIC = 11.63% (NOPAT 783.3m / Invested Capital 6.74b)
WACC = 7.23% (E(5.46b)/V(7.29b) * Re(9.63%)) + (D(1.83b)/V(7.29b) * Rd(0.05%) * (1-Tc(0.22)))
Shares Correlation 3-Years: -57.58 | Cagr: -0.28%
Discount Rate = 9.63% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -256.2m)
Revenue Correlation: -17.09 | Revenue CAGR: 0.70%
Rev Growth-of-Growth: -2.70
EPS Correlation: -14.18 | EPS CAGR: 7.91%
EPS Growth-of-Growth: -20.75
Additional Sources for MTH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle